| scholarly article | Q13442814 |
| P2093 | author name string | Edith R Lederman | |
| Stephanie K Brodine | |||
| Donald Slymen | |||
| Rosemary H Morrison | |||
| Harold Groff | |||
| Mina Said | |||
| Natalie S Hall | |||
| Tamar Rice | |||
| P2860 | cites work | Proton pump inhibitors and risk for recurrent Clostridium difficile infection | Q33574437 |
| Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. | Q33800946 | ||
| Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection | Q34114594 | ||
| Systematic review of the risk of enteric infection in patients taking acid suppression | Q34629190 | ||
| Clostridium difficile--more difficult than ever | Q34868743 | ||
| Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity | Q35874779 | ||
| Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein | Q37230159 | ||
| New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control | Q37251616 | ||
| Clostridium difficile-associated disease in New Jersey hospitals, 2000-2004. | Q37302812 | ||
| Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older | Q37459018 | ||
| A review of mortality due to Clostridium difficile infection | Q37723471 | ||
| Tests for the diagnosis of Clostridium difficile infection: the next generation | Q37849990 | ||
| Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. | Q38470026 | ||
| Risk factors for the development of fulminant Clostridium difficile colitis | Q44103775 | ||
| Predicting Clostridium difficile toxin in hospitalized patients with antibiotic-associated diarrhea | Q44586645 | ||
| Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system | Q45332183 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Clostridium difficile | Q310543 |
| P304 | page(s) | 1173-1178 | |
| P577 | publication date | 2011-10-05 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Risk factors associated with complications and mortality in patients with Clostridium difficile infection | |
| P478 | volume | 53 |
| Q27335693 | A Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management. |
| Q34440654 | A hospital-based study of the clinical characteristics of Clostridium difficile infection in children |
| Q38865456 | Acid-Suppressive Therapy and Risk of Infections: Pros and Cons |
| Q99207543 | Advanced age and increased CRP concentration are independent risk factors associated with Clostridioides difficile infection mortality |
| Q38700386 | Antimicrobial Stewardship in Long-Term Care Facilities: A Call to Action |
| Q40721471 | Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand |
| Q59126532 | Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical Trials |
| Q51740247 | Bezlotoxumab for prevention of recurrent C. difficile infection in patients at increased risk for recurrence. |
| Q37356094 | Clinical factors associated with development of severe-complicated Clostridium difficile infection |
| Q38919522 | Clostridium Difficile Associated Disease: Burden of and Predictors for in Hospital Fatal Outcome. Results of a Hospital-Based Study, Bucharest, Romania |
| Q38448301 | Clostridium difficile Infection in Long-term Care Facilities: A Call to Action for Antimicrobial Stewardship |
| Q51198637 | Clostridium difficile colitis acquired in the intensive care unit: outcome and prognostic factors. |
| Q35213257 | Clostridium difficile in western Romania: unfavourable outcome predictors in a hospital for infectious diseases |
| Q36523431 | Clostridium difficile infection in patients with chronic kidney disease |
| Q36826679 | Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain |
| Q58691973 | Evaluation of risk factors for a fulminant Clostridium difficile infection after cardiac surgery: a single-center, retrospective cohort study |
| Q36311457 | Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort |
| Q41076074 | Factors Predicting Recurrence of Clostridium difficile Infection (CDI) in Hospitalized Patients: Retrospective Study of More Than 2000 Patients |
| Q64232660 | Hypoalbuminemia as predictor of recurrence of Clostridium difficile infection |
| Q34456650 | ICU-Onset Clostridium difficile infection in a university hospital in China: a prospective cohort study |
| Q48312394 | Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study |
| Q37358642 | Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care |
| Q57496117 | Predictors of Mortality Among a National Cohort of Veterans With Recurrent Infection |
| Q38703751 | Prevalence and Clinical Outcomes of Clostridium difficile Infection in the Intensive Care Unit: A Systematic Review and Meta-Analysis |
| Q63348912 | Prognosis of Clostridium difficile infection in adult oncohaematological patients: experience from a large prospective observational study |
| Q92839296 | Proton pump inhibitors and 180-day mortality in the elderly after Clostridium difficile treatment |
| Q37317503 | Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication |
| Q27021390 | Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review |
| Q89560454 | The Clinical Burden of Clostridioides difficile in Ontario, Canada |
| Q36911587 | The Clostridium difficile cpr locus is regulated by a noncontiguous two-component system in response to type A and B lantibiotics |
| Q55103812 | Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection. |
Search more.